Factors associated with the hospitalization of COVID-19 patients in a clinic’s intensive care unit in 2020

Authors

DOI:

https://doi.org/10.24265/horizmed.2021.v21n1.09

Keywords:

Biomarkers, Inflammation, Coronavirus infections

Abstract

Objective: To identify the factors associated with the hospitalization of COVID-19 patients in an intensive care unit. Materials and methods: An observational, cross-sectional and analytical study. The sample consisted of COVID-19 patients treated at the Clínica Good Hope from April to June 2020. The variables were: outcome (place of hospitalization: intensive care unit or internal medicine service) and exposure (age, sex, disease period, comorbidities and laboratory tests such as levels of lactate dehydrogenase, ferritin, D-dimer and C-reactive protein). A descriptive, bivariate analysis and a simple GLM Poisson regression were performed to calculate the odds ratio (OR). Results: Seventy-six (76) patients were evaluated (60 in the internal medicine service and 16 in the intensive care unit). The mean age was 52 years and males prevailed (81.6 %). Elevated serum levels of lactate dehydrogenase, D-dimer and C-reactive protein were associated with a 0.02 % more chance of admission to the intensive care unit at the time of hospitalization, which is statistically significant (OR: 1.002, 95 % CI: 1.001 - 1.003; OR: 1.05, 95 % CI: 1.01 - 1.10; and OR: 1.06, 95 % CI: 1.02 - 1.09). Conclusions: The levels of lactate dehydrogenase, D-dimer and C-reactive protein are associated with the admission to an intensive care unit during hospitalization and could reflect the severity of the disease.

Downloads

Download data is not yet available.

References

Ministerio de Salud. Casos confirmados por Coronavirus Covid-19 ascienden a 244 388 en el Perú (Comunicado N° 137) [Internet]. Lima; 2020. Disponible en: https://www.gob.pe/institucion/minsa/noticias/187617-minsa-casos-confirmados-por-coronavirus-covid-19-ascienden-a-244-388-en-el-peru-comunicado-n-137

Ministerio de Salud. Covid 19 en el Perú - Sala situacional [Internet]. Lima; 2020. Disponible en: https://covid19.minsa.gob.pe/sala_situacional.asp

Shi Y, Wang G, Cai X-P, Deng J-W, Zheng L, Zhu H-H, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020; 21: 343-60.

Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020; 24(1): 188.

Henry BM, Santos De Oliveira MH, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020; 58(7): 1021-8.

Du R-H, Liang L-R, Yang C-Q, Wang W, Cao T-Z, Li M, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV- 2: A prospective cohort study. Eur Respir J. 2020; 55(5): 2000524.

Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020; 1-11.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054-62.

Ahn D-G, Shin H-J, Kim M-H, Lee S, Kim H-S, Myoung J, et al. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol. 2020; 30(3): 313-24.

Fan BE, Lian Chong VC, Wei Chan SS, Lim GH, Eric Lim KG, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020; 95(6): E131-4.

Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infec Dis. 2020; 95: 304-7.

Lagadinou M, Salomou EE, Zareifopoulos N, Marangos M, Gogos C, Velissaris D. Prognosis of COVID-19: Changes in laboratory parameters. Le Infez Med. 2020; 28(Suppl. 1): 89-95.

Poggiali E, Zaino D, Immovilli P, Rovero L, Losi G, Dacrema A, et al. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. Clin Chim Acta. 2020; 509: 135-8.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844-7.

Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020; 14: 175346662093717.

Yan D, Liu X-Y, Zhu Y, Huang L, Dan B, Zhang G, et al. Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection. Eur Respir J. 2020; 56(1): 2000799.

Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020; 92(7): 791-6.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5): 846-8.

Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020; 50(4): 332-4.

Gamboa-Acuña B, Guillén-Zambrano R, Lizzetti-Mendoza G, Soto A, Lucchetti-Rodríguez A. Factores asociados a sobrevida en pacientes con co-infección VIH-TBC en el Servicio de Infectología del Hospital Nacional Arzobispo Loayza , Perú, durante los años 2004-2012. Rev Chil Infect. 2018; 35(1): 41-8.

Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020; 92(7): 856-62.

Sahu BR, Kampa RK, Padhi A, Panda AK. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection. Clin Chim Acta. 2020; 509: 91-4.

Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, Bergwelt-Baildon MV, et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020; 146(1): 128-36.

Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal. J Heart Lung Transplant. 2020; 39(5): 405-7.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506.

Wynants L, Van Calster B, Bonten MM, Collins G, Debray TP, De Vos M, et al. Systematic review and critical appraisal of prediction models for diagnosis and prognosis of COVID-19 infection. BMJ. 2020; 369: m1328.

Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients With COVID-19: focus on severity and mortality. Front Public Health. 2020; 8: 152.

Published

2021-03-30

How to Cite

1.
Lozano Y, Palacios EV. Factors associated with the hospitalization of COVID-19 patients in a clinic’s intensive care unit in 2020. Horiz Med [Internet]. 2021Mar.30 [cited 2025May2];21(1):e1379. Available from: https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1379

Issue

Section

Original article